NOMINATIONS ARE CLOSED
This annual award honours a CAPO/ACOP member who, in the opinion of the Awards Committee and the Board of Directors of the association, has made exceptional and enduring career contributions to Psychosocial Oncology.
This award shall be presented to recognize a Canadian individual who, in the opinion of the Awards Committee and the Board of Directors of the association, has made exceptional and enduring career contributions to Psychosocial Oncology.
Eligibility is limited to members in good standing of CAPO (for at least 2 years prior to the nomination).
The Lifetime Achievement Award replaces the original CAPO Award of Excellence. The winners of the original CAPO Award of Excellence are ineligible to receive the Lifetime Achievement Award.
Application for the award will consist of a curriculum vitae or resume of the nominee, together with a letter of nomination and one letter of reference from individuals familiar with the nominee’s contributions. The letter of nomination will specifically state why the nominee is deserving of the award by providing evidence for how the individual has, over the course of their career, given exceptional and enduring career contributions to Psychosocial Oncology in the areas of research, education, clinical practice, and/or policy.
Complete nomination packages must be submitted ONLINE to the Chair(s) of the Awards Committee (c/o the CAPO office) by no later than April 15, 2021.
Nominations and supporting documentation can be submitted in either French or English.
If no suitable recipients are nominated, no award will be given.
There is no monetary value to this award.
Recent winners of the Life Time Achievement award:
2020 – Dr. Doris Howell (ON)
2019 – Dr. Thomas Hack (MB)
2018 – Dr. Gerald M. Devins (ON)
2017 – Dr. Joan Bottorff (BC)
2016 – Gina MacKenzie (BC)
2015 – Diane Manii (ON)
2013 – Dr. Scott M. Sellick (ON)
2012 – Dr. Gary Rodin (ON)
2011 – Dr. Mary Jane Esplen (ON)
2010 – Dr. Harvey Max Chochinov (MB)
Prior to 2010, this award was called the CAPO Award of Excellence. The prior winners of the CAPO Award of Excellence before the change in the award structure were:
2009 – Esther Green (ON)
2008 – Jill Taylor Brown (MB)
2007 – Dr. Lesley Degner (MB)
2006 – Dr. Zeev Rosberger (QC)
2005 – Dr. Barry Bultz (AB)
2004 – Dr. Margaret Fitch (ON)
2020 CAPO Lifetime Achievement Award Recipient:
Dr. Doris Howell
Doris Howell is a health services and supportive care researcher and was inducted into the Fellowship of the American Academy of Nursing in 2019. She completed a PhD at the Institute of Health Policy, Management and Evaluation (IHPME) in the Outcomes and Evaluation Stream, University of Toronto. She is an Emeritus Senior Scientist in the Division of Supportive Care, Princess Margaret Cancer Centre Research Institute and Adjunct Professor (status), Lawrence S. Bloomberg Faculty of Nursing with a cross-appointment in IHPME & Dalla Lana School of Public Health, University of Toronto. She is also an Affiliate Scientist with the ELLICSR Health, Wellness & Cancer Survivorship Centre, University Health Network, ON.
She held appointments as the RBC Chair, Oncology Nursing Research for 15 years until 2019, as Associate Scientist at the Institute for Clinical Evaluative Sciences, University of Toronto and as Co-Director of the Ontario Patient Reported Outcomes (PROs) Symptom and Toxicity (ON-PROST) Applied Research Unit. She was also a member of the executive team for implementation of the Cancer Care Ontario symptom and distress screening program and as an executive member of the Person-Centered Perspective of the Canadian Partnership Against Cancer. As Co-Director of ON-PROST, she and Dr. Liu developed a unique bench to bedside model for selection and testing of multiple PROs across cancer populations including CTCAE and PROMIS measures; and led an implementation study of PROs in ‘real-world’ multi-site oncology practices in Ontario and Quebec. Dr. Howell continues to lead PROs research and is examining the psychosocial impact of cancer and treatment and the role of coping self-efficacy across the illness trajectory in young women with breast cancer (YWBC) as a member of the pan-Canadian RUBY longitudinal cohort study, a longitudinal study in >1200 women over 3 years. Read more...